Evaluating a Dual-Gene qPCR Melting Curve Assay for Rapid Detection of Tuberculosis in Suspected Pulmonary Cases.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2025-02-25 eCollection Date: 2025-01-01 DOI:10.2147/IDR.S498180
Jun Ma, Li Wang, Xubin Zheng, Haiyan Cui, Wei Sha
{"title":"Evaluating a Dual-Gene qPCR Melting Curve Assay for Rapid Detection of Tuberculosis in Suspected Pulmonary Cases.","authors":"Jun Ma, Li Wang, Xubin Zheng, Haiyan Cui, Wei Sha","doi":"10.2147/IDR.S498180","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>New economic, rapid, and efficient diagnostic methods are desirable for the control of tuberculosis. This study aimed to evaluate the performance of a dual-gene qPCR melting curve assay (DGPMC) in detecting tuberculosis among patients with suspected pulmonary tuberculosis.</p><p><strong>Patients and methods: </strong>The DGPMC assay based on <i>rpoB</i> and <i>IS6110</i> gene sequences has been established for detection of <i>Mycobacterium tuberculosis</i>. A prospective study was conducted among adult patients with suspected pulmonary tuberculosis from June 2021 to September 2023 at Shanghai Pulmonary Hospital, China. All patients received symptom assessment, high-resolution chest CT scan, and bronchoscopy. Bronchoalveolar lavage fluid was collected for mycobacterial culture and acid-fast staining, GeneXpert MTB/RIF, and DGPMC assay. The diagnostic performance of DGPMC assay was evaluated against the composite reference standard.</p><p><strong>Results: </strong>Overall, 240 patients were included in this trial, including 80 (33.3%) asymptomatic patients. Clinical diagnosis of tuberculosis was confirmed in 191 (79.6%) patients and 49 (20.4%) patients were confirmed without tuberculosis. The overall sensitivity of the DGPMC assay was 55.0% (95% CI: 47.6-62.1%), and the corresponding specificity was 85.7% (95% CI: 72.1-93.6%) in the diagnosis of tuberculosis. The sensitivity of DGPMC assay was higher than that of GeneXpert test (55.0% vs 47.1%, P = 0.038). The Youden index and weighted Youden index of the DGPMC assay were 40.7% and 28.4%, respectively. Subgroup analyses demonstrated that the sensitivity was 32.4% (95% CI: 22.3-44.4%) in the individuals with negative results for both culture and GeneXpert test. The DGPMC assay performed significantly better than the melting curves based on <i>rpoB</i> gene or <i>IS6110</i> gene alone (P = 0.0000; P = 0.0020).</p><p><strong>Conclusion: </strong>The DGPMC assay is an alternative tool favorable for the detection of tuberculosis in patients with suspected pulmonary tuberculosis, especially in the patients with low bacterial load.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"1135-1147"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871878/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S498180","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: New economic, rapid, and efficient diagnostic methods are desirable for the control of tuberculosis. This study aimed to evaluate the performance of a dual-gene qPCR melting curve assay (DGPMC) in detecting tuberculosis among patients with suspected pulmonary tuberculosis.

Patients and methods: The DGPMC assay based on rpoB and IS6110 gene sequences has been established for detection of Mycobacterium tuberculosis. A prospective study was conducted among adult patients with suspected pulmonary tuberculosis from June 2021 to September 2023 at Shanghai Pulmonary Hospital, China. All patients received symptom assessment, high-resolution chest CT scan, and bronchoscopy. Bronchoalveolar lavage fluid was collected for mycobacterial culture and acid-fast staining, GeneXpert MTB/RIF, and DGPMC assay. The diagnostic performance of DGPMC assay was evaluated against the composite reference standard.

Results: Overall, 240 patients were included in this trial, including 80 (33.3%) asymptomatic patients. Clinical diagnosis of tuberculosis was confirmed in 191 (79.6%) patients and 49 (20.4%) patients were confirmed without tuberculosis. The overall sensitivity of the DGPMC assay was 55.0% (95% CI: 47.6-62.1%), and the corresponding specificity was 85.7% (95% CI: 72.1-93.6%) in the diagnosis of tuberculosis. The sensitivity of DGPMC assay was higher than that of GeneXpert test (55.0% vs 47.1%, P = 0.038). The Youden index and weighted Youden index of the DGPMC assay were 40.7% and 28.4%, respectively. Subgroup analyses demonstrated that the sensitivity was 32.4% (95% CI: 22.3-44.4%) in the individuals with negative results for both culture and GeneXpert test. The DGPMC assay performed significantly better than the melting curves based on rpoB gene or IS6110 gene alone (P = 0.0000; P = 0.0020).

Conclusion: The DGPMC assay is an alternative tool favorable for the detection of tuberculosis in patients with suspected pulmonary tuberculosis, especially in the patients with low bacterial load.

评价双基因qPCR熔解曲线法快速检测疑似肺结核病例。
目的:寻求新的经济、快速、有效的结核病诊断方法。本研究旨在评估双基因qPCR融化曲线法(DGPMC)在疑似肺结核患者中检测结核病的性能。患者和方法:建立了基于rpoB和IS6110基因序列的DGPMC检测结核分枝杆菌的方法。对中国上海肺科医院2021年6月至2023年9月的疑似肺结核成年患者进行了一项前瞻性研究。所有患者均接受症状评估、高分辨率胸部CT扫描和支气管镜检查。收集支气管肺泡灌洗液进行分枝杆菌培养、抗酸染色、GeneXpert MTB/RIF和DGPMC检测。对照综合标准品评价DGPMC法的诊断性能。结果:该试验共纳入240例患者,其中80例(33.3%)无症状患者。临床确诊结核191例(79.6%),未确诊结核49例(20.4%)。DGPMC检测诊断结核病的总灵敏度为55.0% (95% CI: 47.6-62.1%),相应的特异性为85.7% (95% CI: 72.1-93.6%)。DGPMC检测的敏感性高于GeneXpert检测(55.0% vs 47.1%, P = 0.038)。DGPMC法的约登指数和加权约登指数分别为40.7%和28.4%。亚组分析表明,在培养和GeneXpert测试均为阴性的个体中,敏感性为32.4% (95% CI: 22.3-44.4%)。DGPMC法的熔解曲线明显优于rpoB基因法和IS6110基因法(P = 0.0000;P = 0.0020)。结论:DGPMC法是一种适合于疑似肺结核患者,尤其是低菌载量患者的肺结核诊断的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信